Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin
Abstract
BACKGROUND: Necrotizing pneumonia due to Panton-Valentine leukocidin-producing strains of Staphylococcus aureus is associated with a high mortality rate. We sought factors associated with vital outcome in 50 cases occurring from 1986 through 2005. METHODS: We compared the clinical and biological characteristics of 50 patients according to their vital outcome and examined the characteristics of the corresponding S. aureus isolates. RESULTS: The overall mortality rate was 56%, and the median survival time was 10 days. All of the deaths were attributed to S. aureus infection and were secondary to refractory shock and/or respiratory failure. Fatal outcome was associated with classical severity factors, such as the need for mechanical ventilation or inotrope support, and with onset of the acute respiratory distress syndrome. Airway bleeding was strongly associated with fatal outcome (P=.002). Patients who had focal staphylococcal infection before the onset of pneumonia had a significantly lower mortality rate (P=.002). The main biological feature associated with death was leukopenia (P<.001). In multivariate analysis, leukopenia and erythroderma occurring within the first 24 h after admission to the hospital were independently associated with fatal outcome. Erythroderma was not associated with toxic shock syndrome toxin. CONCLUSIONS: Airway bleeding, erythroderma, and leukopenia are associated with fatal outcome from Panton-Valentine leukocidin-positive S. aureus necrotizing pneumonia. More work is needed to develop more efficacious therapy against this highly lethal disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Influenza-staphylococcal coinfections have increased following the emergence of the USA300 and USA400 lineages, and S. aureus has been identified as a common cause of death during the recent H1N1 influenza pandemic.
“Influenza-staphylococcal coinfections have increased following the emergence of the USA300 and USA400 lineages [9,11,30,31], and S. aureus has been identified as a common cause of death during the recent H1N1 influenza pandemic [12,15].”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [31]
PVL has been proposed as a marker for the enhanced virulence of USA300 and USA400 clones, particularly when their ability to cause necrotizing pneumonia in humans has been considered.
“which has been proposed as a marker for the enhanced virulence of USA300 and USA400 clones, particularly when their ability to cause necrotizing pneumonia in humans has been considered [30,31].”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [31]
The recently emerged USA300 and USA400 clones act synergistically with influenza virus.
“the recently emerged USA300 and USA400 clones that have been linked to a surge in necrotizing pneumonia in patients with influenza [9-11, 15, 29-31] act synergistically with influenza virus.”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [31]
The citation lists haven’t been fetched yet
References 34 · Cited by 340
- Authors
- Gillet, Y., Vanhems, P., Lina, G., Bes, M., Vandenesch, F., Floret, D., & Etienne, J.
- Affiliations
- Lyon 1 Université (FR)
- Corresponding author
- Gillet, Y.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-08-01
- Volume
- 45
- Issue
- 3
- Pages
- 315-321
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2040052393
- Cited by
- 340
- References
- 34
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 11 · 2023: 6 · 2022: 8 · 2021: 11 · 2020: 16 · 2019: 14 · 2018: 6 · 2017: 10 · 2016: 18 · 2015: 20 · 2014: 27 · 2013: 24 · 2012: 32
- FWCI
- 18.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Streptococcal Infections and Treatments
- Keywords
- necrotizing pneumonia, community-acquired pneumonia, Staphylococcus aureus, Panton-Valentine leukocidin, mortality risk factors, leukopenia, erythroderma, airway bleeding, acute respiratory distress syndrome, toxic shock syndrome toxin, shock, respiratory failure, mechanical ventilation
- MeSH terms
- Bacterial Toxins, Exotoxins, France, Humans, Influenza, Human, Leukocidins, Influenza A virus, Retrospective Studies, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, Survival Analysis, Treatment Outcome, Community-Acquired Infections, Pneumonia, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review